A role for PLCβ1 in myotonic dystrophies type 1 and 2

RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy

(2011) Manuela Malatesta et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Therapeutics development in myotonic dystrophy type 1

(2011) Erin Pennock Foff et al.   MUSCLE & NERVE

Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells

(2010) E Loro et al.   CELL DEATH AND DIFFERENTIATION

Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells

(2010) Claudia Huichalaf et al.   FASEB JOURNAL

Absence of a differentiation defect in muscle satellite cells from DM2 patients

(2009) Richard Pelletier et al.   NEUROBIOLOGY OF DISEASE

Catalytic activity of nuclear PLC-β1 is required for its signalling function during C2C12 differentiation

(2008) Giulia Ramazzotti et al.   CELLULAR SIGNALLING

Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1

(2008) Elizabeth Salisbury et al.   EXPERIMENTAL CELL RESEARCH

Myotonic dystrophy: Therapeutic strategies for the future

(2008) Thurman M. Wheeler   Neurotherapeutics